top of page

Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.


UK’s First Medical Cannabis Patient Conference
Event review written by Nikol Naydenova In the heart of London, on Great Portland Street, patients, prescribers, cannabis advocates,...
Nikol Naydenova
Nov 10, 20225 min read


Indigenous washing: the exploitation of indigenous people by the pharmaceutical industry
Article written by Jemima Lowe and Kirran Ahmad Indigenous populations¹ are active stewards of our planet and resources, safeguarding 80%...
Jemima Lowe and Kirran Ahmad
Nov 9, 20227 min read


The value of real world evidence: The case of medical cannabis
Authors Anne Katrin Schlag, Rayyan Zafar, Michael Lynskey, Lawrence D Phillips, Alkyoni Athanasiou-Fragkouli, David J Nutt Published...
Professor Michael Lynskey, Dr Anne Schlag and more
Nov 3, 20224 min read


The Case for Overdose Prevention Centres in the UK - An Evidence-based approach
Overdose Prevention Services in the UK Drug-related deaths are a public health crisis in the UK, with many deaths linked to injecting...
Drug Science
Oct 27, 20224 min read


An Exploration of Psychedelics and Creativity
Event review written by Nikol Naydenova At the edge of central London, over 300 people gathered in an Art Deco cinema eager to listen and...
Nikol Naydenova
Oct 26, 20223 min read


Examining the gender dimension in the non-medical use of over the counter and prescription only medication
There is concern regarding gender differences in problematic non-medical over the counter (OTC) and/or prescription only medication (POM) us
Rosalind Gittins, Joseph Tay Wee Teck, and more
Oct 26, 20222 min read


Swiftly scrapped, certainly a failure and tough to enforce - Consequences of the recent Home Office White Paper
In response to the government’s recent White Paper on ‘tough consequences’ for recreational drug use, Drug Science has warned that the...
Drug Science
Oct 18, 20224 min read


Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness
Author Christina Sagioglou, Matthias Forstmann Published October 2, 2022 Abstract Lifetime psychedelic substance use has previously been...
Christina Sagioglou and Matthias Forstmann
Oct 2, 20221 min read


Interdisciplinary Conference on Psychedelic Research 2022
Written by Orla Mallon Things were really ramping up in Europe this September, with the OPEN Foundation hosting their 5th...
Orla Mallon
Oct 1, 20226 min read


A comparative study of the harms of nitrous oxide and poppers using the MCDA approach
Author Plinio M Ferreira, Adam R Winstock, Anne Katrin Schlag, Brigitta Brandner, David Nutt, Graeme Henderson, Ian Miller, Jan Van...
Dr Anne Schlag, Professor David Nutt and more
Sep 23, 20222 min read


Screening and Assessment Tools for Geriatric Psychiatry
#HealthcareStudents
Drug Science
Sep 22, 20221 min read


Screening and Assessment Tools for Adult Psychiatry
#HealthcareStudents
Drug Science
Sep 22, 20221 min read


An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma
Author FL Smith, JC Neill and V Wainwright Published September 7, 2022 Abstract Veterans are at increased risk of experiencing symptoms...
FL Smith, JC Neill and more
Sep 7, 20221 min read


How to read a paper on the short-term impairing effects of cannabis: A selective and critical review of the literature
Author Michael A White, Nicholas R Burns Published August 15, 2022 Abstract The prosecution of cannabis-presence driving offences (in the...
Michael White and Nicholas Burns
Aug 15, 20222 min read


The Psychedelic Access and Research European Alliance
The Psychedelic Access and Research European Alliance (PAREA) has officially launched with an impressive array of wide-ranging support...
PAREA
Aug 8, 20222 min read


The Drug Enforcement Agency listens to psychedelic experts
By Professor David Nutt and James Bunn The Drug Enforcement Agency (DEA) recently withdrew a proposal to ban five psychedelic substances:...
Professor David Nutt and James Bunn
Aug 5, 20224 min read


Legal psilocybin prescriptions in Canada
What is the Special Access Programme? On January 5th 2022, Health Canada amended the Food and Drug Regulations and the Narcotic Control...
Drug Science
Jul 28, 20223 min read


Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident
Author Petter Grahl Johnstad Published July 25, 2022 Abstract Researchers have associated cannabis use with risk for psychosis, cognitive...
Petter Grahl Johnstad
Jul 25, 20222 min read


State naloxone co-prescribing laws show mixed effects on overdose mortality rates
Author MaryKate Duska, Jared M. Rhoads, Elizabeth C. Saunders, Tracy Onega Published July 25, 2022 Objective To examine the relative...
MaryKate Duska, Jared Rhoads and more
Jul 25, 20221 min read


Eating ourselves to death: How food is a drug and what food abuse costs
Author Matthew Robinson Published July 18, 2022 Abstract The objective of this paper is to examine definitions of the terms “drug,” “drug...
Matthew Robinson
Jul 18, 20221 min read


Diamorphine-Assisted Treatment
Diamorphine-assisted treatment is the prescription and provision of hygienic, medical-grade diamorphine to patients in a clinical set-up...
Drug Science
Jul 11, 20222 min read


The Misuse of Drugs Regulations 2001: A case study in poor legislative drafting
Author Cathal T Gallagher Published July 11, 2022 Abstract The Misuse of Drugs Regulations 2001 (MDRs) create exemptions to the offences...
Cathal Gallagher
Jul 11, 20221 min read


User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study
Authors Robin Carhart-Harris, David Nutt Published July 30, 2010 Abstract This study used a web-based questionnaire to investigate user...
Robin Carhart-Harris and Professor David Nutt
Jul 7, 202232 min read


Over One Hundred Years of MDMA Research
Written by Libby Furminger History 3,4-Methylenedioxymethamphetamine (MDMA), also known as Mandy, Molly, Ecstasy or ‘E’, is a class A...
Libby Furminger
Jun 29, 202210 min read
bottom of page
